An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer
Nishat Manzar(Indian Institute of Technology Kanpur), Bushra Ateeq(Indian Institute of Technology Kanpur), Ayush Goel(Fortis Healthcare), Nilesh Gupta(Henry Ford Health System), Shannon Carskadon(Henry Ford Health System), Nallasivam Palanisamy(Henry Ford Health System), Umar Khalid Khan(Indian Institute of Technology Kanpur)
Cited by 0
Related Papers
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|420
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219